Macronutrient intake and prevalence of markers of metabolic syndrome in white UK adult males in the National Diet and Nutrition Survey Rolling Programme 2008–2014 by Harrison, T. et al.
Summer Meeting, 10–12 July 2017, Improving Nutrition in Metropolitan Areas
Macronutrient intake and prevalence of markers of metabolic syndrome in
white UK adult males in the National Diet and Nutrition Survey Rolling
Programme 2008–2014
T. Harrison1, K.E. Lane1, L.M. Boddy2, F. Amirabdollahian3 and I.G. Davies1
1School of Sport Studies, Leisure and Nutrition, Liverpool John Moores University, Liverpool, L17 6BD,
2School of Sports and Exercise Sciences, Liverpool John Moores University, Liverpool, L3 3AF and
3School of Health Sciences, Liverpool Hope University, Liverpool, L16 9JD
The amount of carbohydrates recommended for consumption by current dietary guidelines has been challenged in relation to their
suitability to prevent or manage cardiometabolic (CM) diseases with suggestions that they should be decreased and replaced by pro-
tein or fat(1,2). Others have argued that a more personalised approach is required(3). Aim of this investigation was to assess the poten-
tial impact of lower versus higher consumption of dietary macronutrients and prevalence of CM risk markers in a representative
sample of the UK male white population.
Unweighted data from 642 white adult males aged 19 and over in the National Diet and Nutrition Survey Rolling Programme(4)
(NDNS RP) 2008–2014 with or without metabolic syndrome (MetS)(5) were analysed for associations of dietary macronutrient intake
as percentage food energy (%FE) with CM risk markers. Logistic regression analysis (adjusted for age group and smoking status) was
used to compare the odds ratios [OR] of prevalence of individual markers of MetS between the lowest and highest quartiles of dietary
macronutrient intake as %FE (⩽44 vs. ≥52 for carbohydrates; ⩽31 vs. ≥39 for fats; ⩽15. vs. ≥19 for protein).
There was a signiﬁcant (p < 0·05) reduction in likelihood of MetS (OR, .55; 95 % conﬁdence interval [CI], .34 to .84), and elevated
waist circumference (OR, .50; 95 % CI, .30 to .83) and glucose levels (OR, .51; 95 % CI, .30 to .87) for those in the highest quartile of
carbohydrate %FE intake compared to the lowest quartile, whereas those in the highest quartile of protein %FE intake had a sign-
iﬁcantly (p < 0·05) increased risk of presenting with the same markers of MetS (OR, 1·75; 95 % CI, 1·05 to 2·93; OR, 2·12; 95 % CI,
1·24 to 3·63; and OR, 2·15; 95 % CI, 1·25 to 3·70 respectively). Those with the highest compared to the lowest total dietary fat intake
also presented with elevated CM risk markers, albeit these ﬁndings were not signiﬁcant.
Further investigations need to conﬁrm whether the quality of the macronutrients consumed and overall diet quality(6) has had an
impact on these results. In the context of a personalised approach to nutrition future cohort studies should also provide data that allow
for examining inter-individual variations in responses to dietary macronutrients, especially carbohydrates, to achieve optimum CM
health for a larger proportion of the population.
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CHO%FE FAT%FE PROT%FE
OR
95 % CI for OR
OR
95 % CI for OR
OR
95 % CI for OR
Lower Upper Lower Upper Lower Upper
MetS* .55a .34 .84 1·58 .97 2·56 1·75a 1·05 2·93
TRIG .72 .46 1·14 1·36 .86 2·15 1·18 .73 1·91
HDL-C 1·13 .69 1·87 1·19 .71 1·98 .86 .50 1·47
WC .50a .30 .83 1·28 .78 2·10 2·12a 1·24 3·63
GLUC .51a .30 .87 1·46 .86 2·47 2·15a 1·25 3·70
BP .89 .53 1·49 1·38 .81 2·34 1·19 .68 2·06
*Metabolic Syndrome (MetS) deﬁnition: 3 out of 5 of the following: triglycerides (TRIG) ≥1·7 mmol/L; High-density lipoprotein cholesterol (HDL-C) ⩽1·03 mmol/L
for males; Waist circumference (WC) ≥94 cm for white males; Glucose (GLUC) ≥5·6 mmol/L; Blood pressure (BP) ≥130 mmHg systolic or ≥85 mmHg diastolic
respectively; CHO%FE – total carbohydrates percentage food energy; FAT%FE – total fats food energy; PROT%FE– total protein food energy; OR – odds ratio
(adjusted for age group and smoking status), 1st vs. 4th quartile of intake; CI – conﬁdence interval; a p < 0·05
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